Fycompa 2mg. 4mg. 6mg. 8mg. 10mg. 12mg FC tablet
PDF Leaflet Revision Date: 14 April 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunctive treatment of partial-onset and primary generalised tonic-clonic seizures.
Dosage (summary)
Adults: Start at 2 mg/day, titrate to 4-12 mg/day. Children: Start at 1-2 mg/day based on weight.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding; may decrease contraceptive effectiveness.
Key Drug Interactions
- CYP3A inducers decrease perampanel levels
- Hormonal contraceptives may be less effective
Contraindications
- Hypersensitivity to perampanel or excipients
Common side effects
- Dizziness
- Somnolence
- Aggression
Counselling Points
- Monitor for mood changes
- Avoid driving until effects are known
- Take at bedtime
Serious warnings
- Suicidal ideation
- Severe cutaneous adverse reactions
- Increased risk of falls
Important Disclaimer
The Fycompa 2mg. 4mg. 6mg. 8mg. 10mg. 12mg FC tablet professional information leaflet below is the property of Eisai Pharmaceuticals Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
